Symptoms Associated with Malignant Wounds: A Prospective Case Series

Vincent Maida, Marguerite Ennis, Craig Kuziemsky, Linda Trozzolo

Research output: Contribution to journalArticleResearchpeer-review

Abstract

A significant proportion of cancer patients develop malignant wounds. Malignant wounds are generally nonhealable and are managed with palliative methods. Palliative wound care encompasses the pain and symptom management of such wounds. Sixty-seven of 472 cancer patients from a prospective sequential case series of palliative medicine consultations demonstrated malignant wounds at the time of referral and were studied to determine the most common symptoms and anatomic sites associated with malignant wounds. Data were collected from patients' own reports of up to three wound-related symptoms. Overall, 67.7% of malignant wounds were associated with at least one of the following eight symptoms: pain, mass effect, esthetic distress, exudation, odor, pruritus, bleeding, and crusting; 21.9% of wounds were associated with two or more symptoms; and 11.5% of wounds were associated with three symptoms. The symptom point prevalence was 31.3% for pain, 23.9% for mass effect, 19.4% for esthetic distress, 17.9% for exudation, 11.9% for odor, 6% for pruritus, 6% for bleeding, and 1.5% for crusting. Breast cancer patients had the highest prevalence of malignant wounds (47.1%). The anterior chest wall and breast was the site of 31.2% of wounds. The perineum and genitalia presented with the highest ratio of symptoms per wound (2.2). The results of this study reflect that malignant wounds are associated with a significant symptomatic burden, and reinforces the need for thorough clinical assessment and evaluation of symptoms. Further research is required to define the optimal methods of pain and symptom management for malignant wounds.

LanguageEnglish
Pages206-211
Number of pages6
JournalJournal of Pain and Symptom Management
Volume37
Issue number2
DOIs
Publication statusPublished - Feb 2009
Externally publishedYes

Fingerprint

Wounds and Injuries
Symptom Assessment
Pain Management
Pruritus
Esthetics
Referral and Consultation
Hemorrhage
Pain
Perineum
Genitalia
Thoracic Wall
Palliative Care
Neoplasms
Breast
Breast Neoplasms
Research

Keywords

  • advanced illness
  • cancer
  • Malignant wounds
  • pain
  • palliative wound care
  • prospective
  • symptoms

Cite this

Maida, Vincent ; Ennis, Marguerite ; Kuziemsky, Craig ; Trozzolo, Linda. / Symptoms Associated with Malignant Wounds : A Prospective Case Series. In: Journal of Pain and Symptom Management. 2009 ; Vol. 37, No. 2. pp. 206-211.
@article{a378c5847ce44c1bbbddf67da0cfcc0d,
title = "Symptoms Associated with Malignant Wounds: A Prospective Case Series",
abstract = "A significant proportion of cancer patients develop malignant wounds. Malignant wounds are generally nonhealable and are managed with palliative methods. Palliative wound care encompasses the pain and symptom management of such wounds. Sixty-seven of 472 cancer patients from a prospective sequential case series of palliative medicine consultations demonstrated malignant wounds at the time of referral and were studied to determine the most common symptoms and anatomic sites associated with malignant wounds. Data were collected from patients' own reports of up to three wound-related symptoms. Overall, 67.7{\%} of malignant wounds were associated with at least one of the following eight symptoms: pain, mass effect, esthetic distress, exudation, odor, pruritus, bleeding, and crusting; 21.9{\%} of wounds were associated with two or more symptoms; and 11.5{\%} of wounds were associated with three symptoms. The symptom point prevalence was 31.3{\%} for pain, 23.9{\%} for mass effect, 19.4{\%} for esthetic distress, 17.9{\%} for exudation, 11.9{\%} for odor, 6{\%} for pruritus, 6{\%} for bleeding, and 1.5{\%} for crusting. Breast cancer patients had the highest prevalence of malignant wounds (47.1{\%}). The anterior chest wall and breast was the site of 31.2{\%} of wounds. The perineum and genitalia presented with the highest ratio of symptoms per wound (2.2). The results of this study reflect that malignant wounds are associated with a significant symptomatic burden, and reinforces the need for thorough clinical assessment and evaluation of symptoms. Further research is required to define the optimal methods of pain and symptom management for malignant wounds.",
keywords = "advanced illness, cancer, Malignant wounds, pain, palliative wound care, prospective, symptoms",
author = "Vincent Maida and Marguerite Ennis and Craig Kuziemsky and Linda Trozzolo",
year = "2009",
month = "2",
doi = "10.1016/j.jpainsymman.2008.01.009",
language = "English",
volume = "37",
pages = "206--211",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier",
number = "2",

}

Symptoms Associated with Malignant Wounds : A Prospective Case Series. / Maida, Vincent; Ennis, Marguerite; Kuziemsky, Craig; Trozzolo, Linda.

In: Journal of Pain and Symptom Management, Vol. 37, No. 2, 02.2009, p. 206-211.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Symptoms Associated with Malignant Wounds

T2 - Journal of Pain and Symptom Management

AU - Maida, Vincent

AU - Ennis, Marguerite

AU - Kuziemsky, Craig

AU - Trozzolo, Linda

PY - 2009/2

Y1 - 2009/2

N2 - A significant proportion of cancer patients develop malignant wounds. Malignant wounds are generally nonhealable and are managed with palliative methods. Palliative wound care encompasses the pain and symptom management of such wounds. Sixty-seven of 472 cancer patients from a prospective sequential case series of palliative medicine consultations demonstrated malignant wounds at the time of referral and were studied to determine the most common symptoms and anatomic sites associated with malignant wounds. Data were collected from patients' own reports of up to three wound-related symptoms. Overall, 67.7% of malignant wounds were associated with at least one of the following eight symptoms: pain, mass effect, esthetic distress, exudation, odor, pruritus, bleeding, and crusting; 21.9% of wounds were associated with two or more symptoms; and 11.5% of wounds were associated with three symptoms. The symptom point prevalence was 31.3% for pain, 23.9% for mass effect, 19.4% for esthetic distress, 17.9% for exudation, 11.9% for odor, 6% for pruritus, 6% for bleeding, and 1.5% for crusting. Breast cancer patients had the highest prevalence of malignant wounds (47.1%). The anterior chest wall and breast was the site of 31.2% of wounds. The perineum and genitalia presented with the highest ratio of symptoms per wound (2.2). The results of this study reflect that malignant wounds are associated with a significant symptomatic burden, and reinforces the need for thorough clinical assessment and evaluation of symptoms. Further research is required to define the optimal methods of pain and symptom management for malignant wounds.

AB - A significant proportion of cancer patients develop malignant wounds. Malignant wounds are generally nonhealable and are managed with palliative methods. Palliative wound care encompasses the pain and symptom management of such wounds. Sixty-seven of 472 cancer patients from a prospective sequential case series of palliative medicine consultations demonstrated malignant wounds at the time of referral and were studied to determine the most common symptoms and anatomic sites associated with malignant wounds. Data were collected from patients' own reports of up to three wound-related symptoms. Overall, 67.7% of malignant wounds were associated with at least one of the following eight symptoms: pain, mass effect, esthetic distress, exudation, odor, pruritus, bleeding, and crusting; 21.9% of wounds were associated with two or more symptoms; and 11.5% of wounds were associated with three symptoms. The symptom point prevalence was 31.3% for pain, 23.9% for mass effect, 19.4% for esthetic distress, 17.9% for exudation, 11.9% for odor, 6% for pruritus, 6% for bleeding, and 1.5% for crusting. Breast cancer patients had the highest prevalence of malignant wounds (47.1%). The anterior chest wall and breast was the site of 31.2% of wounds. The perineum and genitalia presented with the highest ratio of symptoms per wound (2.2). The results of this study reflect that malignant wounds are associated with a significant symptomatic burden, and reinforces the need for thorough clinical assessment and evaluation of symptoms. Further research is required to define the optimal methods of pain and symptom management for malignant wounds.

KW - advanced illness

KW - cancer

KW - Malignant wounds

KW - pain

KW - palliative wound care

KW - prospective

KW - symptoms

UR - http://www.scopus.com/inward/record.url?scp=59649125568&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2008.01.009

DO - 10.1016/j.jpainsymman.2008.01.009

M3 - Article

VL - 37

SP - 206

EP - 211

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 2

ER -